Healthcare and Medical Device

The global base editing market is experiencing remarkable growth, fueled by the rising prevalence of genetic diseases and the urgent need for precise gene editing technologies. Valued at $270 million in 2023, this market is projected to reach $549 million by 2028, expanding at an impressive compound annual growth rate (CAGR) of 15.2%. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21238371 Driving this growth is the increasing recognition of the role genetic mutations play in various diseases. As rare and orphan diseases become more prevalent, the demand for innovative therapies has skyrocketed, propelling base editing to the forefront of rare disease research and treatment. Base editing, a cutting-edge technology, offers a more precise alternative to traditional CRISPR-Cas9 methods, potentially minimizing off-target effects. However, ethical and safety concerns remain a significant barrier to its widespread adoption. The inadvertent modifications...

Base Editing Market  in terms of revenue was estimated to be worth $270 million in 2023 and is poised to reach $549 million by 2028, growing at a CAGR of 15.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growing interest in gene editing technologies, including base editing, has attracted substantial funding and investment from both public and private sources. This financial support is crucial for research and development efforts, accelerating the commercialization of base editing technologies. However, ethical & safety concerns are the factors restraining market growth. Download an Illustrative overview:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21238371 Segments Covered Product & Service, Type, Targeted Base, Application, and End User Geographies Covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa Report Highlights Updated financial information / product portfolio of players Key Market Opport...